Novel 1,2,4-triazoles as selective carbonic anhydrase inhibitors showing ancillary anticathepsin B activity
Amit Kumar1, Priyanka Arya1, Simone Giovannuzzi2
1Department of Chemistry, Kurukshetra University, Kurukshetra, Haryana, 136119, India.
Abstract:
Background: Exploration of the multi-target approach considering both human carbonic anhydrase (hCA) IX and XII and cathepsin B is a promising strategy to target cancer. Methodology & Results: 22 novel 1,2,4-triazole derivatives were synthesized and evaluated for their inhibition efficacy against hCA I, II, IX, XII isoforms and cathepsin B. The compounds demonstrated effective inhibition against hCA IX and/or XII isoforms with considerable selectivity over off-target hCA I/II. All compounds presented significant anticathepsin B activities at a low concentration of 10-7 M and in vitro results were also supported by the molecular modeling studies. Conclusion: Insights of present study can be utilized in the rational design of effective and selective hCA IX and XII inhibitors capable of inhibiting cathepsin B.
Insights
Novel 1,2,4-triazole derivatives effectively inhibit cancer-related human carbonic anhydrase (hCA) IX and XII, alongside cathepsin B. These compounds show promise for developing targeted cancer therapies.
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Cancer Research
Background:
- Targeting cancer often involves a multi-target approach.
- Human carbonic anhydrase (hCA) IX and XII, and cathepsin B are key cancer targets.
- Developing selective inhibitors for these targets is crucial.
Purpose of the Study:
- To synthesize and evaluate novel 1,2,4-triazole derivatives.
- To assess their inhibitory potential against hCA I, II, IX, XII, and cathepsin B.
- To explore a multi-target strategy for cancer therapy.
Main Methods:
- Synthesis of 22 novel 1,2,4-triazole derivatives.
- In vitro enzyme inhibition assays for hCA isoforms and cathepsin B.
- Molecular modeling studies to support experimental findings.
Main Results:
- Compounds showed potent inhibition against hCA IX and/or XII.
- High selectivity was observed over off-target hCA I and II isoforms.
- Significant anticathepsin B activity was demonstrated at low concentrations (10-7 M).
- In vitro results were corroborated by molecular modeling.
Conclusions:
- The synthesized compounds are effective dual inhibitors of hCA IX/XII and cathepsin B.
- These findings provide a basis for designing novel cancer therapeutics.
- The study highlights the potential of 1,2,4-triazole derivatives in multi-target cancer therapy.
Related Concept Videos
Antihypertensive Drugs: Thiazide-Class Diuretics
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Diazonium Group Substitution: –OH and –H
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Overview
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Preparation of Acid Anhydrides
The carboxylate ion acts as a nucleophile that attacks the carbonyl carbon of the acid chloride to form a tetrahedral intermediate. Subsequently, the re-formation of the carbonyl group with the loss of the chloride ion as a leaving group leads to the formation of an acid...

![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)
